Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

ARCA biopharma, Inc. (ABIO)

In Vitro & In Vivo Diagnostic Substances

http://www.arcabiopharma.com

ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.

10170 CHURCH RANCH WAY, SUITE 100
WESTMINSTER, CO

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/08/1997

Market Cap

42,795,945

Shares Outstanding

14,410,000

Weighted SO

14,410,143

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

AVTE --.--%

ADAG --.--%

ACRV --.--%

RZLT --.--%

ANTX --.--%

INDP --.--%

TPST --.--%

CMRA --.--%

FBRX --.--%

Beta

0.8950

Last Div

0.0000

Range

1.56-4.49

Chg

0.0500

Avg Vol

83453

Mkt Cap

42795945

Exch

NASDAQ

Country

US

Phone

720 940 2200

DCF Diff

0.3979

DCF

2.5771

Div Yield

0.0000

P/S

243.1588

EV Multiple

-1.0953

P/FV

1.3138

Div Yield %

0.0000

P/E

-5.9438

PEG

-0.1409

Payout

0.0000

Current Ratio

26.6090

Quick Ratio

26.6090

Cash Ratio

26.1865

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

2481.1310

CCC

-2481.1310

Gross Margin

0.5227

Op Margin

-49.7784

Pretax Margin

-40.9091

Net Margin

-40.9091

Eff Tax Rate

-0.1316

ROA

-0.2127

ROE

-0.2018

ROCE

-0.2690

NI/EBT

1.0000

EBT/EBIT

0.8218

EBIT/Rev

-49.7784

Debt Ratio

0.0007

D/E

0.0007

LT Debt/Cap

0.0000

Total Debt/Cap

0.0007

Int Coverage

-19.4689

CF/Debt

-286.9583

Equity Multi

1.0390

Rec Turnover

0.0000

Pay Turnover

0.1471

Inv Turnover

0.0000

FA Turnover

14.6667

Asset Turnover

0.0052

OCF/Share

-0.4747

FCF/Share

-0.4747

Cash/Share

2.2943

OCF/Sales

-39.1307

FCF/OCF

1.0000

CF Coverage

-286.9583

ST Coverage

-286.9583

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

1.3138

P/B

1.3138

P/S

243.1588

P/E

-5.9438

P/FCF

-6.2140

P/OCF

-6.2139

P/CF

-6.2139

PEG

-0.1409

P/S

243.1588

EV Multiple

-1.0953

P/FV

1.3138

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation